These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19666690)

  • 1. Lifestyle intervention: from cost savings to value for money.
    Rappange DR; Brouwer WB; Rutten FF; van Baal PH
    J Public Health (Oxf); 2010 Sep; 32(3):440-7. PubMed ID: 19666690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achievable cost saving and cost-effective thresholds for diabetes prevention lifestyle interventions in people aged 65 years and older: a single-payer perspective.
    Anderson JM
    J Acad Nutr Diet; 2012 Nov; 112(11):1747-54. PubMed ID: 23102174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential economic impacts from improving breastfeeding rates in the UK.
    Pokhrel S; Quigley MA; Fox-Rushby J; McCormick F; Williams A; Trueman P; Dodds R; Renfrew MJ
    Arch Dis Child; 2015 Apr; 100(4):334-40. PubMed ID: 25477310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of HIV prevention programs.
    Holtgrave DR; Qualls NL; Graham JD
    Annu Rev Public Health; 1996; 17():467-88. PubMed ID: 8724236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of hypertension therapy according to 2014 guidelines.
    Moran AE; Odden MC; Thanataveerat A; Tzong KY; Rasmussen PW; Guzman D; Williams L; Bibbins-Domingo K; Coxson PG; Goldman L
    N Engl J Med; 2015 Jan; 372(5):447-55. PubMed ID: 25629742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost savings associated with improving appropriate and reducing inappropriate preventive care: cost-consequences analysis.
    Hogg W; Baskerville N; Lemelin J
    BMC Health Serv Res; 2005 Mar; 5(1):20. PubMed ID: 15755330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making the economic case for prevention--a view from Wales.
    Hale J; Phillips CJ; Jewell T
    BMC Public Health; 2012 Jun; 12():460. PubMed ID: 22716189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio.
    van Baal PH; Feenstra TL; Hoogenveen RT; de Wit GA; Brouwer WB
    Health Econ; 2007 Apr; 16(4):421-33. PubMed ID: 17039573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simulation of affordability and effectiveness of childhood obesity interventions.
    Ma S; Frick KD
    Acad Pediatr; 2011; 11(4):342-50. PubMed ID: 21764018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
    Palmer AJ; Tucker DM
    Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of nephrolithiasis is cost-effective for a national healthcare system.
    Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
    BJU Int; 2012 Dec; 110(11 Pt C):E1060-7. PubMed ID: 22686216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?
    Rappange DR; van Baal PH; van Exel NJ; Feenstra TL; Rutten FF; Brouwer WB
    Pharmacoeconomics; 2008; 26(10):815-30. PubMed ID: 18793030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health policy interventions: the pathway to public health].
    Andersen K; Gudnason V
    Laeknabladid; 2013 Mar; 99(3):129-34. PubMed ID: 23486685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic effect of Planet Health on preventing bulimia nervosa.
    Wang LY; Nichols LP; Austin SB
    Arch Pediatr Adolesc Med; 2011 Aug; 165(8):756-62. PubMed ID: 21810638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financing Mechanisms for Reducing Adversity and Enhancing Resilience Through Implementation of Primary Prevention.
    Steverman SM; Shern DL
    Acad Pediatr; 2017; 17(7S):S144-S149. PubMed ID: 28865648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of skin cancer prevention in Australia.
    Shih ST; Carter R; Sinclair C; Mihalopoulos C; Vos T
    Prev Med; 2009 Nov; 49(5):449-53. PubMed ID: 19747936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost savings and cost-effectiveness of clinical preventive care.
    Neumann PJ; Cohen JT
    Synth Proj Res Synth Rep; 2009 Sep; (18):. PubMed ID: 22052182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness of prevention: opportunities for public health policy in the Netherlands].
    van den Berg M; de Wit GA; Vijgen SM; Busch MC; Schuit AJ
    Ned Tijdschr Geneeskd; 2008 Jun; 152(23):1329-34. PubMed ID: 18661860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.